Company Filing History:
Years Active: 2025
Title: Guohua Lou: Innovator in Liver Cancer Diagnosis
Introduction
Guohua Lou is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of genetic engineering and medical diagnosis, particularly in the area of liver cancer detection. His innovative work focuses on the development of serum miRNA markers that aid in diagnosing liver cancer and predicting its metastasis.
Latest Patents
Guohua Lou holds a patent for "Serum miRNA markers for diagnosing liver cancer and predicting liver cancer metastasis and detection kit thereof." This patent, which is a crucial advancement in medical diagnostics, involves the use of three specific blood miRNA markers related to human liver cancer. The markers identified in his research are serum-derived miR-122-5p, miR-144-3p, and miR-451a. The detection kit developed from this research is designed for early diagnosis and assessment of metastasis risk in liver cancer patients.
Career Highlights
Lou is affiliated with Zhejiang University, where he continues to engage in groundbreaking research. His work has not only contributed to the scientific community but has also provided practical applications in clinical settings. The detection kit he developed has undergone optimization of reaction conditions and reagent ratios, establishing a standardized process for clinical detection and analysis.
Collaborations
Guohua Lou has collaborated with notable colleagues, including Min Zheng and Shuangshuang Li. Their combined efforts have further advanced the research and development of innovative diagnostic tools in the field of oncology.
Conclusion
Guohua Lou's contributions to liver cancer diagnosis through innovative serum miRNA markers exemplify the impact of research in medical science. His work continues to pave the way for improved diagnostic methods and better patient outcomes.